These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8482311)

  • 1. Effects of PGE1 in experimental vasoconstrictive pulmonary hypertension.
    Dagher E; Dumont L; Chartrand C; Blaise G
    Eur Surg Res; 1993; 25(2):65-73. PubMed ID: 8482311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amrinone and dobutamine on PGF2 alpha-induced pulmonary hypertension in dogs.
    Dumont L; Dagher E
    Eur Surg Res; 1994; 26(4):201-9. PubMed ID: 7957456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular pressure-flow plots in canine oleic acid pulmonary edema. Effects of prostaglandin E1 and nitroprusside.
    Leeman M; Lejeune P; Mélot C; Naeije R
    Am Rev Respir Dis; 1988 Aug; 138(2):362-7. PubMed ID: 3143286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of inhaled prostanoids in experimental pulmonary hypertension.
    Kleen M; Habler O; Hofstetter C; Pusch R; Mueller M; Welte M; Zwissler B
    Crit Care Med; 1998 Jun; 26(6):1103-9. PubMed ID: 9635662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. About mechanisms of prostaglandin E1 induced deterioration of pulmonary gas exchange in COPD patients.
    Dujić Z; Eterović D; Tocilj J; Kusić Z; Capkun V
    Clin Physiol; 1993 Sep; 13(5):497-506. PubMed ID: 8222534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of right atrial infusion of PGE1 in sepsis-induced pulmonary hypertension.
    Marini CP; Woloszyn T; Coons M; Tachmes L; Nathan I; Cunningham JN; Jacobowitz IJ
    J Surg Res; 1990 Dec; 49(6):476-82. PubMed ID: 2124641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prostaglandin E1 in reducing pulmonary vascular resistance in an experimental model of acute lung injury.
    Dervin G; Calvin JE
    Crit Care Med; 1990 Oct; 18(10):1129-33. PubMed ID: 2209041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
    Heerdt PM; Weiss CI
    Ann Thorac Surg; 1990 Mar; 49(3):463-5. PubMed ID: 2106846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 antagonizes hypoxic pulmonary vasoconstriction but reduces systemic blood pressure in dogs.
    Ishibe Y; Shiokawa Y; Umeda T; Uno H; Nakamura M; Izumi T
    Crit Care Med; 1998 Jan; 26(1):126-31. PubMed ID: 9428554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vascular and hemodynamic effects of prostaglandin E1 in unanesthetized sheep.
    Ogletree ML; Brigham KL
    Microcirc Endothelium Lymphatics; 1984 Jun; 1(3):307-27. PubMed ID: 6546148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism.
    Ducas J; Girling L; Schick U; Prewitt RM
    Circulation; 1986 May; 73(5):1050-7. PubMed ID: 3698227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S; Xiao M; Liu Y
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
    Naeije R; Mélot C; Mols P; Hallemans R
    Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of arterial oxygenation by selective infusion of prostaglandin E1 to ventilated lung during one-lung ventilation.
    Chen TL; Ueng TH; Huang CH; Chen CL; Huang FY; Lin CJ
    Acta Anaesthesiol Scand; 1996 Jan; 40(1):7-13. PubMed ID: 8904253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
    Delcroix M; Mélot C; Lejeune P; Leeman M; Naeije R
    Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of different dosage of PGE1 in pulmonary arterial hypertension].
    Guo ZH; Ye YQ; Jing BW
    Zhonghua Nei Ke Za Zhi; 1993 Sep; 32(9):591-3. PubMed ID: 8112140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.